Evidence map›Paper›PMID 24740788›Full record

ArticleAmerican journal of physiology. Renal physiology2014

COX-2 mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.

Fei Wang, Xiaohan Lu, Kexin Peng, Li Zhou, Chunling Li, Weidong Wang, Xueqing Yu, Donald E Kohan, Shu-Feng Zhu, Tianxin Yang

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Collecting duct renin regulates potassium homeostasis in mice.Acta physiologica (Oxford, England) · 2023
    Article
  4. Article
  5. Review
  6. NaHypertension (Dallas, Tex. : 1979) · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. The (pro)renin receptor in health and disease.Nature reviews. Nephrology · 2019
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Prostaglandin EThe American journal of the medical sciences · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Fei WangInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China; Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah; and.
Xiaohan LuInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China; Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah; and.
Kexin PengInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China; Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah; and.
Li ZhouInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China;
Chunling LiInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China;
Weidong WangInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China;
Xueqing YuDepartment of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China;
Donald E KohanInternal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah; and.
Shu-Feng ZhuDepartment of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, Florida.
Tianxin YangInstitute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China; Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah; and Tianxin.Yang@hsc.utah.edu.
Sun Yat-sen University · CNUniversity of Utah · USUniversity of South Florida · US

Funding

Interaction of PGE2 and intrarenal RAS in AngII-induced hypertensionR01DK104072 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI YANG, TIANXIN · 2015 to 2025
$3.7M
Control of collecting duct function by lipid-derived factors in obesityR01DK094956 · NIDDK · UNIVERSITY OF UTAH · PI YANG, TIANXIN · 2013 to 2017
$1.6M
mPGES-1/EP1 in volume regulationI01BX001034 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI YANG, TIANXIN · 2011 to 2014
–
BLRD VA I01 BX001034NIDDK NIH HHS DK094956NIDDK NIH HHS R01 DK094956NIDDK NIH HHS R01 DK104072
6 · The paper itself

Abstract

(Pro)renin receptor (PRR) is predominantly expressed in the distal nephron where it is activated by angiotensin II (ANG II), resulting in increased renin activity in the renal medulla thereby amplifying the de novo generation and action of local ANG II. The goal of the present study was to test the role of cycloxygenase-2 (COX-2) in meditating ANG II-induced PRR expression in the renal medulla in vitro and in vivo. Exposure of primary rat inner medullary collecting duct cells to ANG II induced sequential increases in COX-2 and PRR protein expression. When the cells were pretreated with a COX-2 inhibitor NS-398, ANG II-induced upregulation of PRR protein expression was almost completely abolished, in parallel with the changes in medium active renin content. The inhibitory effect of NS-398 on the PRR expression was reversed by adding exogenous PGE2. A 14-day ANG II infusion elevated renal medullary PRR expression and active and total renin content in parallel with increased urinary renin, all of which were remarkably suppressed by the COX-2 inhibitor celecoxib. In contrast, plasma and renal cortical active and total renin content were suppressed by ANG II treatment, an effect that was unaffected by COX-2 inhibition. Systolic blood pressure was elevated with ANG II infusion, which was attenuated by the COX-2 inhibition. Overall, the results obtained from in vitro and in vivo studies established a crucial role of COX-2 in mediating upregulation of renal medullary PRR expression and renin content during ANG II hypertension.

Indexed as

Angiotensin IIAnimalsCyclooxygenase 2Cyclooxygenase 2 InhibitorsDisease Models, AnimalKidneyMaleRatsRats, Sprague-DawleyReninAngiotensin IICyclooxygenase 2Cyclooxygenase 2 InhibitorsPtgs2 protein, ratRenincyclooxygenase-2inner medullary collecting duct(pro)renin receptorprostaglandin E2renin activity

Identifiers

PMID24740788
PMCPMC4080156
OpenAlexW2072822532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.